Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chubb
Cipla
US Department of Justice
Teva
Baxter

Generated: July 15, 2019

DrugPatentWatch Database Preview

Drug Master Files for: haloperidol

Try a free trialSee Plans and Pricing

« Back to Dashboard


haloperidol Drug Master Files

DMF No. Status Type Submission Date Holder Subject
10946 A II 6/13/1994 JANSSEN PHARMACEUTICA NV HALOPERIDOL (R001625) DRUG SUBSTANCE
10954 A II 6/23/1994 JANSSEN PHARMACEUTICA NV HALOPERIDOL DECANOATE
12530 A II 5/28/1997 TEVA PHARMACEUTICAL INDUSTRIES LTD HALOPERIDOL DECANOATE
14226 A II 6/22/1999 EXCELLA GMBH AND CO KG HALOPERIDOL
15279 I III 10/4/2000 PLASDENE GLASS PAK EFFECTS OF BIPERIDEN ON THE PHARMACOKINETICS OF HALOPERIDOL
16949 A II 11/10/2003 OLON SPA HALOPERIDOL DECANOATE
19197 I II 2/21/2006 EXCELLA GMBH HALOPERIDOL DECANOATE
DMF No. Status Type Submission Date Holder Subject

Subscribe to access the full database, or try a Free Trial


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Argus Health
AstraZeneca
Cantor Fitzgerald
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.